메뉴 건너뛰기




Volumn 134, Issue 3, 2009, Pages 431-433

The value of hydration and acetylcysteine in the prevention of contrast-induced nephropathy: A potentially catastrophic complication of the percutaneous coronary interventions

Author keywords

Acetylcysteine; Contrast induced nephropathy; Hydration

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; BICARBONATE; SODIUM CHLORIDE;

EID: 67349262495     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.12.123     Document Type: Article
Times cited : (5)

References (23)
  • 1
    • 43049162220 scopus 로고    scopus 로고
    • Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine
    • Chen S.L., Zhang J., Yei F., et al. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine. Int J Cardiol. 126 (2008) 407-413
    • (2008) Int J Cardiol. , vol.126 , pp. 407-413
    • Chen, S.L.1    Zhang, J.2    Yei, F.3
  • 2
    • 46449137187 scopus 로고    scopus 로고
    • Prevention of radiocontrast media-induced acute renal failure
    • Rose B.D. (Ed), UpToDate, Wellesley
    • Rudnick M.R., and Tumlin J.A. Prevention of radiocontrast media-induced acute renal failure. In: Rose B.D. (Ed). UpToDate00 (2006), UpToDate, Wellesley
    • (2006) UpToDate00
    • Rudnick, M.R.1    Tumlin, J.A.2
  • 3
    • 0028490756 scopus 로고
    • Contrast nephrotoxicity
    • Barrett B.J. Contrast nephrotoxicity. J Am Soc Nephrol 5 (1994) 125-137
    • (1994) J Am Soc Nephrol , vol.5 , pp. 125-137
    • Barrett, B.J.1
  • 4
    • 3042852243 scopus 로고    scopus 로고
    • Prevention of radiocontrast-induced nephropathy
    • Asif A., and Epstein M. Prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 44 (2004) 12-24
    • (2004) Am J Kidney Dis , vol.44 , pp. 12-24
    • Asif, A.1    Epstein, M.2
  • 5
    • 33745283670 scopus 로고    scopus 로고
    • Prophylaxis strategies for contrast-induced nephropathy
    • Pannu N., Wiebe N., and Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA 295 (2006) 2765-2779
    • (2006) JAMA , vol.295 , pp. 2765-2779
    • Pannu, N.1    Wiebe, N.2    Tonelli, M.3
  • 6
    • 0028936849 scopus 로고
    • Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial
    • Rudnick M.R., Goldfarb S., Wexler L., et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 47 (1995) 254-261
    • (1995) Kidney Int , vol.47 , pp. 254-261
    • Rudnick, M.R.1    Goldfarb, S.2    Wexler, L.3
  • 7
    • 0030661687 scopus 로고    scopus 로고
    • Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality
    • McCullough P.A., Wolyn R., Rocher L.L., Levin R.N., and O'Neill W.W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103 (1997) 368-375
    • (1997) Am J Med , vol.103 , pp. 368-375
    • McCullough, P.A.1    Wolyn, R.2    Rocher, L.L.3    Levin, R.N.4    O'Neill, W.W.5
  • 8
    • 33646135329 scopus 로고    scopus 로고
    • Safety of low-dose radiocontrast for interventional AV fistula salvage in stage 4 chronic kidney disease patients
    • Kian K., Wyatt C., Schon D., Packer J., Vassalotti J., and Mishler R. Safety of low-dose radiocontrast for interventional AV fistula salvage in stage 4 chronic kidney disease patients. Kidney Int 69 (2006) 1444-1449
    • (2006) Kidney Int , vol.69 , pp. 1444-1449
    • Kian, K.1    Wyatt, C.2    Schon, D.3    Packer, J.4    Vassalotti, J.5    Mishler, R.6
  • 9
    • 0037059951 scopus 로고    scopus 로고
    • Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty
    • Mueller C., Buerkle G., Buettner H.J., et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162 (2002) 329-336
    • (2002) Arch Intern Med , vol.162 , pp. 329-336
    • Mueller, C.1    Buerkle, G.2    Buettner, H.J.3
  • 10
    • 2442590642 scopus 로고    scopus 로고
    • Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial
    • Merten G.J., Burgess W.P., Gray L.V., et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291 (2004) 2328-2334
    • (2004) JAMA , vol.291 , pp. 2328-2334
    • Merten, G.J.1    Burgess, W.P.2    Gray, L.V.3
  • 11
    • 2442542222 scopus 로고    scopus 로고
    • Prevention of radiocontrast nephropathy: back to basics
    • Chertow G.M. Prevention of radiocontrast nephropathy: back to basics. JAMA 291 (2004) 2376-2377
    • (2004) JAMA , vol.291 , pp. 2376-2377
    • Chertow, G.M.1
  • 12
    • 10744229574 scopus 로고    scopus 로고
    • N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials
    • Kshirsagar A.V., Poole C., Mottl A., et al. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. J Am Soc Nephrol 15 (2004) 761-769
    • (2004) J Am Soc Nephrol , vol.15 , pp. 761-769
    • Kshirsagar, A.V.1    Poole, C.2    Mottl, A.3
  • 14
    • 0347990333 scopus 로고    scopus 로고
    • Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials
    • Alonso A., Lau J., Jaber B.L., Weintraub A., and Sarnak M.J. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am J Kidney Dis 43 (2004) 1-9
    • (2004) Am J Kidney Dis , vol.43 , pp. 1-9
    • Alonso, A.1    Lau, J.2    Jaber, B.L.3    Weintraub, A.4    Sarnak, M.J.5
  • 15
    • 1642545171 scopus 로고    scopus 로고
    • Systematic review of the impact of N-acetylcysteine on contrast nephropathy
    • Pannu N., Manns B., Lee H., and Tonelli M. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int 65 (2004) 1366-1374
    • (2004) Kidney Int , vol.65 , pp. 1366-1374
    • Pannu, N.1    Manns, B.2    Lee, H.3    Tonelli, M.4
  • 16
    • 18244395035 scopus 로고    scopus 로고
    • N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis
    • Liu R., Nair D., Ix J., Moore D.H., and Bent S. N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis. J Gen Intern Med 20 (2005) 193-200
    • (2005) J Gen Intern Med , vol.20 , pp. 193-200
    • Liu, R.1    Nair, D.2    Ix, J.3    Moore, D.H.4    Bent, S.5
  • 18
    • 29144523846 scopus 로고    scopus 로고
    • N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials
    • Zagler A., Azadpour M., Mercado C., and Hennekens C.H. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials. Am Heart J 151 (2006) 140-145
    • (2006) Am Heart J , vol.151 , pp. 140-145
    • Zagler, A.1    Azadpour, M.2    Mercado, C.3    Hennekens, C.H.4
  • 19
    • 0037419923 scopus 로고    scopus 로고
    • Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial
    • Kay J., Chow W.H., Chan T.M., et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 289 (2003) 553-558
    • (2003) JAMA , vol.289 , pp. 553-558
    • Kay, J.1    Chow, W.H.2    Chan, T.M.3
  • 20
    • 0034691822 scopus 로고    scopus 로고
    • Prevention of radiographic-contrast-agent-induced reduction in renal function by acetylcysteine
    • Tepel M., Van Der Giet M., Schwarzfeld C., Laufer U., Liermann D., and Zidek W. Prevention of radiographic-contrast-agent-induced reduction in renal function by acetylcysteine. N Engl J Med 343 (2000) 180-184
    • (2000) N Engl J Med , vol.343 , pp. 180-184
    • Tepel, M.1    Van Der Giet, M.2    Schwarzfeld, C.3    Laufer, U.4    Liermann, D.5    Zidek, W.6
  • 21
    • 0942265438 scopus 로고    scopus 로고
    • The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable
    • Hoffmann U., Fischereder M., Kruger B., Drobnik W., and Kramer B.K. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 15 (2004) 407-410
    • (2004) J Am Soc Nephrol , vol.15 , pp. 407-410
    • Hoffmann, U.1    Fischereder, M.2    Kruger, B.3    Drobnik, W.4    Kramer, B.K.5
  • 22
    • 33745641529 scopus 로고    scopus 로고
    • N-acetylcysteine and contrast-induced nephropathy in primary angioplasty
    • Marenzi G., Assanelli E., Marana I., et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 354 (2006) 2773-2782
    • (2006) N Engl J Med , vol.354 , pp. 2773-2782
    • Marenzi, G.1    Assanelli, E.2    Marana, I.3
  • 23
    • 10744233453 scopus 로고    scopus 로고
    • Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity
    • Briguori C., Colombo A., Violante A., et al. Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J 25 (2004) 206-211
    • (2004) Eur Heart J , vol.25 , pp. 206-211
    • Briguori, C.1    Colombo, A.2    Violante, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.